 Bone Neoplasms
"Bone Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer located in bone tissue or specific BONES.
| Descriptor ID |
D001859
|
| MeSH Number(s) |
C04.588.149 C05.116.231
|
| Concept/Terms |
Bone Neoplasms- Bone Neoplasms
- Bone Neoplasm
- Neoplasm, Bone
- Neoplasms, Bone
|
Below are MeSH descriptors whose meaning is more general than "Bone Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Bone Neoplasms".
This graph shows the total number of publications written about "Bone Neoplasms" by people in this website by year, and whether "Bone Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 10 | 1 | 11 | | 1991 | 10 | 2 | 12 | | 1992 | 9 | 3 | 12 | | 1993 | 12 | 2 | 14 | | 1994 | 8 | 4 | 12 | | 1995 | 20 | 8 | 28 | | 1996 | 18 | 6 | 24 | | 1997 | 18 | 6 | 24 | | 1998 | 15 | 8 | 23 | | 1999 | 12 | 9 | 21 | | 2000 | 16 | 6 | 22 | | 2001 | 24 | 4 | 28 | | 2002 | 18 | 9 | 27 | | 2003 | 32 | 10 | 42 | | 2004 | 42 | 14 | 56 | | 2005 | 35 | 8 | 43 | | 2006 | 37 | 18 | 55 | | 2007 | 55 | 9 | 64 | | 2008 | 46 | 7 | 53 | | 2009 | 44 | 13 | 57 | | 2010 | 49 | 14 | 63 | | 2011 | 65 | 16 | 81 | | 2012 | 47 | 11 | 58 | | 2013 | 50 | 6 | 56 | | 2014 | 61 | 8 | 69 | | 2015 | 51 | 6 | 57 | | 2016 | 48 | 9 | 57 | | 2017 | 48 | 6 | 54 | | 2018 | 26 | 8 | 34 | | 2019 | 34 | 7 | 41 | | 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Bone Neoplasms" by people in Profiles.
-
Agrawal N, DeFazio MV, Bird JE, Mericli AF. Computer-Aided Design and Computer-Aided Manufacturing for Pelvic Tumor Resection and Free Fibula Flap Reconstruction. Plast Reconstr Surg. 2020 04; 145(4):889e-890e.
-
Wu CC, Beird HC, Andrew Livingston J, Advani S, Mitra A, Cao S, Reuben A, Ingram D, Wang WL, Ju Z, Hong Leung C, Lin H, Zheng Y, Roszik J, Wang W, Patel S, Benjamin RS, Somaiah N, Conley AP, Mills GB, Hwu P, Gorlick R, Lazar A, Daw NC, Lewis V, Futreal PA. Immuno-genomic landscape of osteosarcoma. Nat Commun. 2020 02 21; 11(1):1008.
-
Young EP, Cheng WS, Bernhardt MB, Wang LL, Rainusso N, Foster JH. Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcoma. Pediatr Blood Cancer. 2020 04; 67(4):e28123.
-
Coleman R, Finkelstein DM, Barrios C, Martin M, Iwata H, Hegg R, Glaspy J, Periañez AM, Tonkin K, Deleu I, Sohn J, Crown J, Delaloge S, Dai T, Zhou Y, Jandial D, Chan A. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2020 01; 21(1):60-72.
-
Schafer ES, Rau RE, Berg SL, Liu X, Minard CG, Bishop AJR, Romero JC, Hicks MJ, Nelson MD, Voss S, Reid JM, Fox E, Weigel BJ, Blaney SM. Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411). Pediatr Blood Cancer. 2020 02; 67(2):e28073.
-
Jiao S, Subudhi SK, Aparicio A, Ge Z, Guan B, Miura Y, Sharma P. Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy. Cell. 2019 Nov 14; 179(5):1177-1190.e13.
-
Yevich S, Tselikas L, Kelekis A, Filippiadis D, de Baere T, Deschamps F. Percutaneous management of metastatic osseous disease. Chin Clin Oncol. 2019 Dec; 8(6):62.
-
Nomura M, Rainusso N, Lee YC, Dawson B, Coarfa C, Han R, Larson JL, Shuck R, Kurenbekova L, Yustein JT. Tegavivint and the ß-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma. J Natl Cancer Inst. 2019 11 01; 111(11):1216-1227.
-
Coleman R. Clinical benefits of bone targeted agents in early breast cancer. Breast. 2019 Nov; 48 Suppl 1:S92-S96.
-
Nan X, Wang J, Cheng H, Yin Z, Sheng J, Qiu B, Lau CC, Yustein JT, Zhao H, Wong STC. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways. Cancer Lett. 2020 01 28; 469:195-206.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|